Actionable biomarker co-expression in advanced ovarian cancer: folate receptor alpha expression and related markers

By afschroeder • August 26, 2026

Shachar EK, Silverstein J, Gornbein J, Salani R, Karlan BY, Chase DM. Actionable biomarker co-expression in advanced ovarian cancer: folate receptor alpha expression and related markers. Int J Gynecol Cancer. 2026 Aug 6:104893. doi: 10.1016/j.ijgc.2026.104893. Epub ahead of print. PMID: 42642279.

Tags: biomarkers, Co-Expression, DOM STAT, estrogen receptor, Folate receptor alpha, General Internal Medicine, Hematology/Oncology, ovarian cancer, Publications

Manuel Celedon, MD Appointed Inaugural Chief of the Division of Addiction Medicine, Department of Medicine at the VA Greater Los Angeles Healthcare System

We are pleased to announce the appointment of Manuel Celedon, MD, as the inaugural chief of the Division of Addiction Medicine within the Department of[...]

Response to Spillover Effects in Randomized Evaluations of Translational AI

Leuchter RK, Turner WB, Ouyang D. Response to Spillover Effects in Randomized Evaluations of Translational AI. NEJM AI. 2026 Mar;3(3):AIp2600014. doi: 10.1056/AIp2600014. Epub 2026 Feb[...]

Letter: Spillover Effects in Randomized Evaluations of Translational AI

Mann S, Berdahl CT. Letter: Spillover Effects in Randomized Evaluations of Translational AI. NEJM AI. 2026 Mar;3(3):AIp2501326. doi: 10.1056/AIp2501326. Epub 2026 Feb 26. PMID: 42932501.